Peer-reviewed veterinary case report
Multiplex analysis of cytokines in the cerebrospinal fluid of dogs after ischemic stroke reveals elevations in chemokines CXCL1 and MCP-1.
- Journal:
- Frontiers in veterinary science
- Year:
- 2023
- Authors:
- Barber, Renee M et al.
- Affiliation:
- Department of Small Animal Medicine and Surgery · United States
- Species:
- dog
Abstract
INTRODUCTION: Neuroinflammation that occurs in the brain after stroke has been shown to be important to disease pathogenesis and outcomes. The aim of this study was to evaluate a large number of pro- and anti-inflammatory cytokines in dogs with clinically-confirmed, naturally occurring stroke. MATERIALS AND METHODS: Fifteen dogs with a clinical diagnosis of ischemic stroke and ten healthy control dogs were included in the study. A multiplex immunoassay was utilized to evaluate cerebrospinal fluid for GM-CSF, IFN-γ, IL-2, IL-4, IL-6, IL-7, IL-8, IL-10, IL-15, IL-18, IP-10, CXCL1, MCP-1, and TNF-α. RESULTS: Mean concentrations of CXCL1 (stroke-436 pg/ml, control-267 pg/ml,= 0.01) and MCP-1 (stroke-196 pg/ml, control-66 pg/ml,≤ 0.0001) were significantly elevated in dogs with stroke when compared with control dogs. Location and type of infarct, duration of clinical signs, and use of anti-inflammatory medications were not associated with differences in cytokine concentration. DISCUSSION: CXCL1 and MCP-1 may play a role in naturally occurring canine stroke and represent targets for future research.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication: https://pubmed.ncbi.nlm.nih.gov/37266378/